Clin2
NCT07051603Likely a fitRecruiting

Safety study of SAL0140 in healthy Chinese adults

Uncontrolled Hypertension

Treatments studied

Part of Heart & circulation clinical trials.

This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
82 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be a healthy adult between 18 and 65 years old.
  • Your weight and body mass index (BMI) must be within a certain range.
  • You cannot have used certain medications, supplements, or herbal remedies in the past 14 days.
  • You must not have a history of certain heart conditions or low blood pressure upon standing.
  • You cannot smoke, drink too much alcohol or caffeine, or donate blood for a period before and during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07152444Not yet recruiting· Phase 1
Testing QLS1410 in healthy adults and those with mild high blood pressure

This trial tests a new drug called QLS1410. It is given once to healthy volunteers and to people with mild high blood pressure to see how the body handles it and if it lowers blood pressure safely.

Beijing
NCT07722299Not yet recruiting· Phase 1
Safety study of SAL0167 in healthy volunteers

This trial tests a new drug called SAL0167 in healthy people to see if it is safe and how the body processes it. The study has two parts: Part A includes all healthy volunteers, and Part B focuses on people with moderately high cholesterol.

Guangzhou, Guangdong
NCT07647133Not yet recruiting· Phase 2
Testing SAL0140 doses for kidney disease with protein in urine

This trial tests whether a new drug called SAL0140 can help people with chronic kidney disease who have protein leaking into their urine. The study will look at different doses to find the safest and most effective amount.

Shenzhen, Guangdong
NCT07646535Not yet recruiting· Phase 2
SAL0140 study for primary aldosteronism and high blood pressure

This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.

Shanghai, Shanghai Municipality
NCT07609875Not yet recruiting· Phase 1
Safety study of HS-10522 blood pressure medication in healthy adults

This study tests a new experimental blood pressure medication called HS-10522 to see if it is safe and how the body processes it. Researchers will give the medication to healthy adults and those with mild high blood pressure to understand its effects.

Hear when a new Uncontrolled Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.